ログイン

ISBB

ISBB
100問 • 1年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    Which two organs are considered the primary lymphoid organs in which immunocompetent cells originate and mature? A. Thyroid and Peyer’s patches B. Thymus and bone marrow C. Spleen and mucosal-associated lymphoid tissue (MALT) D. Lymph nodes and thoracic duct

    B. Thymus and bone marrow

  • 2

    What type of B cells are formed after antigen stimulation? A. Plasma cells and memory B cells B. Mature B cells C. Antigen-dependent B cells D. Receptor-activated B cells

    A. Plasma cells and memory B cells

  • 3

    T cells travel from the bone marrow to the thymus for maturation. What is the correct order of the maturation sequence for T cells in the thymus? A. Bone marrow to the cortex; after thymic education, released back to peripheral circulation B. Maturation and selection occur in the cortex; migration to the medulla; release of mature T cells to secondary lymphoid organs C. Storage in either the cortex or medulla; release of T cells into the peripheral circulation D. Activation and selection occur in the medulla; mature T cells are stored in the cortex until activated by antigen

    B. Maturation and selection occur in the cortex; migration to the medulla; release of mature T cells to secondary lymphoid organs

  • 4

    Which cluster of differentiation (CD) marker appears during the first stage of T-cell development and remains present as an identifying marker for T cells? A. CD1 B. CD2 C. CD3 D. CD4 or CD8

    B. CD2

  • 5

    Which markers are found on mature, peripheral helper T cells? A. CD1, CD2, CD4 B. CD2, CD3, CD8 C. CD1, CD3, CD4 D. CD2, CD3, CD4

    D. CD2, CD3, CD4

  • 6

    Which T cell expresses the CD8 marker and acts specifically, to kill tumors or virally infected cells? A. Helper T B. T suppressor C. T cytotoxic D. T inducer/suppressor

    C. T cytotoxic

  • 7

    How are cytotoxic T cells (TC cells) and natural killer (NK) cells similar? A. Require antibody to be present B. Effective against virally infected cells C. Recognize antigen in association with HLA class II markers D. Do not bind to infected cells

    B. Effective against virally infected cells

  • 8

    What is the name of the process by which phagocytic cells are attracted to a substance such as a bacterial peptide? A. Diapedesis B. Degranulation C. Chemotaxis D. Phagotaxis

    C. Chemotaxis

  • 9

    Which complement component is found in both the classic and alternative pathways? A. C1 B. C4 C. Factor D D. C3

    D. C3

  • 10

    Which immunoglobulin(s) help(s) initiate the classic complement pathway? A. IgA and IgD B. IgM only C. IgG and IgM D. IgG only

    C. IgG and IgM

  • 11

    How is complement activity destroyed in vitro? A. Heating serum at 56°C for 30 min B. Keeping serum at room temperature of 22°C for 1 hour C. Heating serum at 37°C for 45 min D. Freezing serum at 0°C for 24 hours

    A. Heating serum at 56°C for 30 min

  • 12

    Which region of the immunoglobulin molecule can bind antigen? A. Fab B. Fc C. CL D. CH

    A. Fab

  • 13

    What is the purpose of C3a, C4a, and C5a, the split products of the complement cascade? A. To bind with specific membrane receptors of lymphocytes and cause release of cytotoxic substances B. To cause increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils C. To bind with membrane receptors of macrophages to facilitate phagocytosis and the removal of debris and foreign substances D. To regulate and degrade membrane cofactor protein after activation by C3 convertase

    B. To cause increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils

  • 14

    Which region determines whether an immunoglobulin molecule can fix complement? A. VH B. CH C. VL D. CL

    B. CH

  • 15

    Which immunoglobulin class(es) has (have) a J chain? A. IgM B. IgE and IgD C. IgM and sIgA D. IgG3 and IgA

    C. IgM and sIgA

  • 16

    Which immunoglobulin appears first in the primary immune response? A. IgG B. IgM C. IgA D. IgE

    B. IgM

  • 17

    Which immunoglobulin appears in highest titer in the secondary response? A. IgG B. IgM C. IgA D. IgE

    A. IgG

  • 18

    Which immunoglobulin can cross the placenta? A. IgG B. IgM C. IgA D. IgE

    A. IgG

  • 19

    Which immunoglobulin cross links mast cells to release histamine? A. IgG B. IgM C. IgA D. IgE

    D. IgE

  • 20

    All of the following are functions of immunoglobulins except: A. Neutralizing toxic substances B. Facilitating phagocytosis through opsonization C. Interacting with TC cells to lyse viruses D. Combining with complement to destroy cellular Antigens

    C. Interacting with TC cells to lyse viruses

  • 21

    Which of the following cell surface molecules is classified as an MHC class II antigen? A. HLA-A B. HLA-B C. HLA-C D. HLA-DR

    D. HLA-DR

  • 22

    Which of the following are products of HLA class III genes? A. T-cell immune receptors B. HLA-D antigens on immune cells C. Complement proteins C2, C4, and Factor B D. Immunoglobulin VL regions

    C. Complement proteins C2, C4, and Factor B

  • 23

    What molecule on the surface of most T cells recognizes antigen? A. IgT, a four-chain molecule that includes the tau heavy chain B. MHC protein, a two-chain molecule encoded by the HLA region C. CD3, consisting of six different chains D. TcR, consisting of two chains, alpha and beta

    D. TcR, consisting of two chains, alpha and beta

  • 24

    The T-cell antigen receptor is similar to immunoglobulin molecules in that it: A. Remains bound to the cell surface and is never secreted B. Contains V and C regions on each of its chains C. Binds complement D. Can cross the placenta and provide protection to a fetus

    B. Contains V and C regions on each of its chains

  • 25

    Toll-like receptors are found on which cells? A. T cells B. Dendritic cells C. B cells D. Large granular lymphocytes

    B. Dendritic cells

  • 26

    Macrophages produce which of the following proteins during antigen processing? A. IL-1 and IL-6 B. γ-Interferon C. IL-4, IL-5, and IL-10 D. Complement components C1 and C3

    A. IL-1 and IL-6

  • 27

    T regulator cells, responsible for controlling autoimmune antibody production, express which of the following phenotypes? A. CD3, CD4, CD8 B. CD3, CD8, CD25 C. CD3, CD4, CD25 D. CD8, CD25, CD56

    C. CD3, CD4, CD25

  • 28

    A superantigen, such as toxic shock syndrome toxin-1 (TSST-1), bypasses the normal antigen processing stage by binding to and cross linking: A. A portion of an immunoglobulin molecule and complement component C1 B. Toll-like receptors and an MHC class 1 molecule C. A portion of an immunoglobulin and a portion of a T-cell receptor D. A portion of a T-cell receptor and an MHC class II molecule

    D. A portion of a T-cell receptor and an MHC class II molecule

  • 29

    The interaction between an individual antigen and antibody molecule depends upon several types of bonds such as ionic bonds, hydrogen bonds, hydrophobic bonds, and van der Waals forces. How is the strength of this attraction characterized? A. Avidity B. Affinity C. Reactivity D. Valency

    B. Affinity

  • 30

    A laboratory is evaluating an enzyme-linked immunosorbent assay (ELISA) for detecting an antibody to cyclic citrullinated peptide (CCP), which is a marker for rheumatoid arthritis. The laboratory includes serum from healthy volunteers and patients with other connective tissue diseases in the evaluation. These specimens determine which factor of the assay? A. Sensitivity B. Precision C. Bias D. Specificity

    D. Specificity

  • 31

    The detection of precipitation reactions depends on the presence of optimal proportions of antigen and antibody. A patient’s sample contains a large amount of antibody, but the reaction in a test system containing antigen is negative. What has happened? A. Performance error B. Low specificity C. A shift in the zone of equivalence D. Prozone phenomenon

    D. Prozone phenomenon

  • 32

    Which part of the radial immunodiffusion (RID) test system contains the antisera? A. Center well B. Outer wells C. Gel D. Antisera may be added to any well

    C. Gel

  • 33

    What is the interpretation when an Ouchterlony plate shows crossed lines between wells 1 and 2 (antigen is placed in the center well and antisera in wells 1 and 2)? A. No reaction between wells 1 and 2 B. Partial identity between wells 1 and 2 C. Nonidentity between wells 1 and 2 D. Identity between wells 1 and 2

    C. Nonidentity between wells 1 and 2

  • 34

    Why is a chemiluminescent immunoassay (CIA) or enzyme immunoassay (EIA) the method of choice for detection of certain analytes, such as hormones, normally found in low concentrations? A. Because of low cross reactivity B. Because of high specificity C. Because of high sensitivity D. Because test systems may be designed as both competitive and noncompetitive assays

    C. Because of high sensitivity

  • 35

    What comprises the indicator system in an indirect ELISA for detecting antibody? A. Enzyme-conjugated antibody + chromogenic substrate B. Enzyme conjugated antigen + chromogenic substrate C. Enzyme + antigen D. Substrate + antigen

    A. Enzyme-conjugated antibody + chromogenic substrate

  • 36

    What outcome results from improper washing of a tube or well after adding the enzyme–antibody conjugate in an ELISA system? A. Result will be falsely decreased B. Result will be falsely increased C. Result will be unaffected D. Result is impossible to determine

    B. Result will be falsely increased

  • 37

    What would happen if the color reaction phase is prolonged in one tube or well of an ELISA test? A. Result will be falsely decreased B. Result will be falsely increased C. Result will be unaffected D. Impossible to determine

    B. Result will be falsely increased

  • 38

    Which type of nephelometry is used to measure immune complex formation almost immediately after reagent has been added? A. Rate B. Endpoint C. Continuous D. One dimensiona

    A. Rate

  • 39

    The absorbance of a sample measured by ELISA is greater than the highest standard. What corrective action should be taken? A. Extrapolate an estimated value from the highest reading B. Repeat the test using a standard of higher concentration C. Repeat the assay using one half the volume of the sample D. Dilute the test sample

    D. Dilute the test sample

  • 40

    A patient was suspected of having a lymphoproliferative disorder. After several laboratory tests were completed, the patient was found to have an IgMκ paraprotein. In what sequence should the laboratory tests leading to this diagnosis have been performed? A. Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE) B. Immunoglobulin levels followed by SPE C. Total lymphocyte count followed by immunoglobulin levels D. Immunoglobulin levels followed by urine protein electrophoresis

    A. Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE)

  • 41

    An IFE performed on a serum sample showed a narrow dark band in the lanes containing anti-γ and anti-λ. How should this result be interpreted? A. Abnormally decreased IgG concentration B. Abnormal test result demonstrating monoclonal IgGλ C. Normal test result D. Impossible to determine without densitometric quantitation

    B. Abnormal test result demonstrating monoclonal IgGλ

  • 42

    An immunofluorescence microscopy assay (IFA) was performed, and a significant antibody titer was reported. Positive and negative controls performed as expected. However, the clinical evaluation of the patient was not consistent with a positive finding. What is the most likely explanation of this situation? A. The clinical condition of the patient changed since the sample was tested B. The pattern of fluorescence was misinterpreted C. The control results were misinterpreted D. The wrong cell line was used for the tes

    B. The pattern of fluorescence was misinterpreted

  • 43

    What corrective action should be taken when an indeterminate pattern occurs in an indirect IFA? A. Repeat the test using a larger volume of sample B. Call the physician C. Have another medical laboratory scientist read the slide D. Dilute the sample and retest

    D. Dilute the sample and retest

  • 44

    Which statement best describes passive agglutination reactions used for serodiagnosis? A. Such agglutination reactions are more rapid because they are a single-step process B. Reactions require the addition of a second antibody C. Passive agglutination reactions require biphasic incubation D. Carrier particles for antigen such as latex particles are used

    D. Carrier particles for antigen such as latex particles are used

  • 45

    What has happened in a titer, if tube Nos. 5–7 show a stronger reaction than tube Nos.1–4? A. Prozone reaction B. Postzone reaction C. Equivalence reaction D. Poor technique

    A. Prozone reaction

  • 46

    What is the titer in tube No. 8 if tube No. 1 is undiluted and dilutions are doubled? A. 64 B. 128 C. 256 D. 512

    B. 128

  • 47

    The directions for a slide agglutination test instruct that after mixing the patient’s serum and latex particles, the slide must be rotated for 2 minutes. What would happen if the slide were rotated for 10 minutes? A. Possible false-positive result B. Possible false-negative result C. No effect D. Depends on the amount of antibody present in the sample

    A. Possible false-positive result

  • 48

    Which outcome indicates a negative result in a complement fixation test? A. Hemagglutination B. Absence of hemagglutination C. Hemolysis D. Absence of hemolysis

    C. Hemolysis

  • 49

    What effect does selecting the wrong gate have on the results when cells are counted by flow cytometry? A. No effect B. Failure to count the desired cell population C. Falsely elevated results D. Impossible to determine

    B. Failure to count the desired cell population

  • 50

    Which statement best describes immunophenotyping? A. Lineage determination by detecting antigens on the surface of the gated cells using fluorescent antibodies B. Identification of cell maturity using antibodies to detect antigens within the nucleus C. Identification and sorting of cells by front and sidescatter of light from a laser D. Analysis of cells collected by flow cytometry using traditional agglutination reactions

    A. Lineage determination by detecting antigens on the surface of the gated cells using fluorescent antibodies

  • 51

    A flow cytometry scattergram of a bone marrow sample shows a dense population of cells located inbetween normal lymphoid and normal myeloid cells. What is the most likely explanation? A. The sample was improperly collected B. An abnormal cell population is present C. The laser optics are out of alignment D. The cells are most likely not leukocytes

    B. An abnormal cell population is present

  • 52

    What substance is detected by the rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests for syphilis? A. Cardiolipin B. Anticardiolipin antibody C. Anti-T. pallidum antibody D. Treponema pallidum

    B. Anticardiolipin antibody

  • 53

    What type of antigen is used in the RPR card test? A. Live treponemal organisms B. Killed suspension of treponemal organisms C. Cardiolipin D. Tanned sheep cells

    C. Cardiolipin

  • 54

    Which of the following is the most sensitive test to detect congenital syphilis? A. VDRL B. RPR C. Microhemagglutinin test for T. pallidum (MHA-TP) D. Polymerase chain reaction (PCR)

    D. Polymerase chain reaction (PCR)

  • 55

    A biological false-positive reaction is least likely with which test for syphilis? A. VDRL B. Fluorescent T. pallidum antibody absorption test (FTA-ABS) C. RPR D. All are equally likely to detect a false-positive Result

    B. Fluorescent T. pallidum antibody absorption test (FTA-ABS)

  • 56

    A 12-year-old girl has symptoms of fatigue and a localized lymphadenopathy. Laboratory tests reveal a peripheral blood lymphocytosis, a positive RPR, and a positive spot test for IM. What test should be performed next? A. HIV test by ELISA B. VDRL C. Epstein–Barr virus (EBV) specific antigen test D. Treponema pallidum particle agglutination (TP-PA) test

    D. Treponema pallidum particle agglutination (TP-PA) test

  • 57

    Which test is most likely to be positive in the tertiary stage of syphilis? A. FTA-ABS B. RPR C. VDRL D. Reagin screen test (RST)

    A. FTA-ABS

  • 58

    What is the most likely interpretation of the following syphilis serological results? A. Neurosyphilis B. Secondary syphilis C. Syphilis that has been successfully treated D. Biological false positive

    D. Biological false positive

  • 59

    Interpret the following quantitative RPR test results. A. Excess antibody, prozone effect B. Excess antigen, postzone effect C. Equivalence of antigen and antibody D. Impossible to interpret; testing error

    A. Excess antibody, prozone effect

  • 60

    Tests to identify infection with HIV fall into which three general classification types of tests? A. Tissue culture, antigen, and antibody tests B. Tests for antigens, antibodies, and nucleic acid C. DNA probe, DNA amplification, and Western blot tests D. ELISA, Western blot, and Southern blot tests

    B. Tests for antigens, antibodies, and nucleic acid

  • 61

    A woman who has had five pregnancies subsequently tests positive for HIV by Western blot. What is the most likely reason for this result? A. Possible cross-reaction with herpes or EBV antibodies B. Interference from medication C. Cross-reaction with HLA antigens in the antigen preparation D. Possible technical error

    C. Cross-reaction with HLA antigens in the antigen preparation

  • 62

    Interpret the following results for HIV infection. A. Positive for antibodies to human immunodeficiency virus, HIV-1 B. Positive for antibodies to human immunodeficiency virus, HIV-2 C. Cross reaction; biological false-positive result D. Additional testing required

    D. Additional testing required

  • 63

    What is the most likely explanation when antibody tests for HIV are negative but a polymerase chain reaction test performed 1 week later is positive? A. Probably not HIV infection B. Patient is in the “window phase” before antibody production C. Tests were performed incorrectly D. Clinical signs may be misinterpreted

    B. Patient is in the “window phase” before antibody production

  • 64

    What criteria constitute the classification system for HIV infection? A. CD4-positive T-cell count and clinical symptoms B. Clinical symptoms, condition, duration, and number of positive bands on Western blot C. Presence or absence of lymphadenopathy D. Positive bands on Western blot and CD8-positive T-cell count

    A. CD4-positive T-cell count and clinical symptoms

  • 65

    What is the main difficulty associated with the development of an HIV vaccine? A. The virus has been difficult to culture; antigen extraction and concentration are extremely laborious B. Human trials cannot be performed C. Different strains of the virus are genetically diverse D. Anti-idiotype antibodies cannot be developed

    C. Different strains of the virus are genetically diverse

  • 66

    What is the advantage of 4th-generation rapid HIV tests over earlier rapid HIV tests? A. They use recombinant antigens B. They detect multiple strains of HIV C. They detect p24 antigen D. They are quantitative

    C. They detect p24 antigen

  • 67

    Which method is used to test for HIV infection in infants who are born to HIV-positive mothers? A. ELISA B. Western blot test C. Polymerase chain reaction D. Viral culture

    C. Polymerase chain reaction

  • 68

    What is the most likely cause when a Western blot or ELISA is positive for all controls and samples? A. Improper pipetting B. Improper washing C. Improper addition of sample D. Improper reading

    B. Improper washing

  • 69

    What constitutes a diagnosis of viral hepatitis? A. Abnormal test results for liver enzymes B. Clinical signs and symptoms C. Positive results for hepatitis markers D. All of these options

    D. All of these options

  • 70

    Which of the following statements regarding infection with hepatitis D virus is true? A. Occurs in patients with HIV infection B. Does not progress to chronic hepatitis C. Occurs in patients with hepatitis B D. Is not spread through blood or sexual contact

    C. Occurs in patients with hepatitis B

  • 71

    All of the following hepatitis viruses are spread through blood or blood products except: A. Hepatitis A B. Hepatitis B C. Hepatitis C D. Hepatitis D

    A. Hepatitis A

  • 72

    Which hepatitis B marker is the best indicator of early acute infection? A. HBsAg B. HBeAg C. Anti-HBc D. Anti-HBs

    A. HBsAg

  • 73

    Which is the first antibody detected in serum after infection with hepatitis B virus (HBV)? A. Anti-HBs B. Anti-HBc IgM C. Anti-HBe D. All are detectable at the same time

    B. Anti-HBc IgM

  • 74

    Which antibody persists in low-level carriers of hepatitis B virus? A. IgM anti-HBc B. IgG anti-HBc C. IgM anti-HBe D. IgG anti-HBs

    B. IgG anti-HBc

  • 75

    Which hepatitis antibody confers immunity against reinfection with hepatitis B virus? A. Anti-HBc IgM B. Anti-HBc IgG C. Anti-HBe D. Anti-HBs

    D. Anti-HBs

  • 76

    What is the most likely explanation when a patient has clinical signs of viral hepatitis but tests negative for hepatitis A IgM, hepatitis B surface antigen, and hepatitis C Ab? A. Tests were performed improperly B. The patient does not have hepatitis C. The patient may be in the “core window” D. Clinical evaluation was performed improperly

    C. The patient may be in the “core window”

  • 77

    Which hepatitis B markers should be performed on blood products? A. HBsAg and anti-HBc B. Anti-HBs and anti-HBc C. HBeAg and HBcAg D. Anti-HBs and HBeAg

    A. HBsAg and anti-HBc

  • 78

    Which test, other than serological markers, is most consistently elevated in viral hepatitis? A. Antinuclear antibodies B. Alanine aminotransferase (ALT) C. Absolute lymphocyte count D. Lactate dehydrogenase

    B. Alanine aminotransferase (ALT)

  • 79

    If only anti-HBs is positive, which of the following can be ruled out? A. Hepatitis B virus vaccination B. Distant past infection with hepatitis B virus C. Hepatitis B immune globulin (HBIG) injection D. Chronic hepatitis B virus infection

    D. Chronic hepatitis B virus infection

  • 80

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 81

    Which statement concerning non-Forssman heterophile antibody is true? A. It is not absorbed by guinea pig antigen B. It is absorbed by guinea pig antigen C. It does not agglutinate horse RBCs D. It does not agglutinate sheep RBCs

    A. It is not absorbed by guinea pig antigen

  • 82

    Given a heterophile antibody titer of 224, which of the following results indicate IM?

    A

  • 83

    Given a heterophile antibody titer of 224, which of the following results indicate serum sickness?

    C

  • 84

    4. Given a heterophile antibody titer of 224, which of the following results indicate an error in testing?

    B

  • 85

    Blood products are tested for which virus before being transfused to newborns? A. EBV B. Human T-lymphotropic virus II (HTLV-II) C. Cytomegalovirus (CMV) D. Hepatitis D virus

    C. Cytomegalovirus (CMV)

  • 86

    What is the endpoint for the antistreptolysin O (ASO) latex agglutination assay? A. Highest serum dilution that shows no agglutination B. Highest serum dilution that shows agglutination C. Lowest serum dilution that shows agglutination D. Lowest serum dilution that shows no agglutination

    B. Highest serum dilution that shows agglutination

  • 87

    Interpret the following ASO results: A. Positive Todd unit 125 B. Positive Todd unit 166 C. No antistreptolysin O present D. Impossible to interpret

    A. Positive Todd unit 125

  • 88

    Which control shows the correct result for a valid ASO test? A. SLO control, no hemolysis B. Red cell control, no hemolysis C. Positive control, hemolysis in all tubes D. Hemolysis in both SLO and red cell control

    B. Red cell control, no hemolysis

  • 89

    A streptozyme test was performed, but the result was negative, even though the patient showed clinical signs of a streptococcal throat infection. What should be done next? A. Either ASO or anti-deoxyribonuclease B (antiDNase B) testing B. Another streptozyme test using diluted serum C. Antihyaluronidase testing D. Wait for 3–5 days and repeat the streptozyme test

    A. Either ASO or anti-deoxyribonuclease B (antiDNase B) testing

  • 90

    Rapid assays for influenza that utilize specimens obtained from nasopharyngeal swabs detect: A. IgM anti-influenza B. IgA anti-influenza C. IgA-influenza Ag immune complexes D. Influenza antigen

    D. Influenza antigen

  • 91

    How can interfering cold agglutinins be removed from a test sample? A. Centrifuge the serum and remove the top layer B. Incubate the clot at 1°C–4°C for several hours, then remove serum C. Incubate the serum at 56°C in a water bath for 30 minutes D. Use an anticoagulated sample

    B. Incubate the clot at 1°C–4°C for several hours, then remove serum

  • 92

    All tubes (dilutions) except the negative control are positive for cold agglutinins. This indicates: A. Contaminated red cells B. A rare antibody against red cell antigens C. The sample was stored at 4°C prior to separating serum and cells D. Further serial dilution is necessary

    D. Further serial dilution is necessary

  • 93

    All positive cold agglutinin tubes remain positive after 37°C incubation except the positive control. What is the most likely explanation for this situation? A. High titer cold agglutinins B. Contamination of the test system C. Antibody other than cold agglutinins D. Faulty water bath

    C. Antibody other than cold agglutinins

  • 94

    Which increase in antibody titer (dilution) best indicates an acute infection? A. From 1:2 to 1:8 B. From 1:4 to 1:16 C. From 1:16 to 1:256 D. From 1:64 to 1:128

    C. From 1:16 to 1:256

  • 95

    Which of the following positive antibody tests may be an indication of recent vaccination or early primary infection for rubella in a patient with no clinical symptoms? A. Only IgG antibodies positive B. Only IgM antibodies positive C. Both IgG and IgM antibodies positive D. Fourfold rise in titer for IgG antibodies

    B. Only IgM antibodies positive

  • 96

    Why is laboratory diagnosis difficult in cases of Lyme disease? A. Clinical response may not be apparent upon initial infection; IgM antibody may not be detected until 3–6 weeks after the infection B. Laboratory tests may be designed to detect whole Borrelia burgdorferi, not flagellar antigen found early in infection C. Most laboratory tests are technically demanding and lack specificity

    A. Clinical response may not be apparent upon initial infection; IgM antibody may not be detected until 3–6 weeks after the infection

  • 97

    Serological tests for which disease may give a false positive result if the patient has Lyme disease? A. AIDS B. Syphilis C. Cold agglutinins D. Hepatitis C

    B. Syphilis

  • 98

    In monitoring an HIV-infected patient, which parameter may be expected to be the most sensitive indicator of the effectiveness of antiretroviral treatment? A. HIV antibody titer B. CD4:CD8 ratio C. HIV viral load D. Absolute total T-cell count

    C. HIV viral load

  • 99

    A renal transplant recipient is found to have a rising creatinine level and reduced urine output. The physician orders a “Urine PCR” assay. When you call to find out what organism the physician wants to identify, you are told: A. Hepatitis C virus B. Legionella pneumophila C. EBV D. BK virus

    D. BK virus

  • 100

    A newborn is to be tested for a vertically transmitted HIV infection. Which of the following tests is most useful? A. HIV PCR B. CD4 count C. Rapid HIV antibody test D. HIV IgM antibody tes

    A. HIV PCR

  • HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    Yves Laure Pimentel · 69問 · 2年前

    HISTOPATHOLOGY

    HISTOPATHOLOGY

    69問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    Yves Laure Pimentel · 89問 · 2年前

    OTHER BODY FLUIDS

    OTHER BODY FLUIDS

    89問 • 2年前
    Yves Laure Pimentel

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    Yves Laure Pimentel · 86問 · 2年前

    MTLBE- SUHO NOTES

    MTLBE- SUHO NOTES

    86問 • 2年前
    Yves Laure Pimentel

    MTLBE..

    MTLBE..

    Yves Laure Pimentel · 35問 · 2年前

    MTLBE..

    MTLBE..

    35問 • 2年前
    Yves Laure Pimentel

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    Yves Laure Pimentel · 19問 · 1年前

    CC- CHROMATOGRAPHY

    CC- CHROMATOGRAPHY

    19問 • 1年前
    Yves Laure Pimentel

    CC-OSMOMETRY

    CC-OSMOMETRY

    Yves Laure Pimentel · 14問 · 1年前

    CC-OSMOMETRY

    CC-OSMOMETRY

    14問 • 1年前
    Yves Laure Pimentel

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    Yves Laure Pimentel · 43問 · 1年前

    CC-ELECTROCHEMISTRY TECHNIQUES

    CC-ELECTROCHEMISTRY TECHNIQUES

    43問 • 1年前
    Yves Laure Pimentel

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    Yves Laure Pimentel · 49問 · 2年前

    CC- CARBOHYDRATES

    CC- CARBOHYDRATES

    49問 • 2年前
    Yves Laure Pimentel

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    Yves Laure Pimentel · 97問 · 2年前

    CC- DIABETES MELLITUS

    CC- DIABETES MELLITUS

    97問 • 2年前
    Yves Laure Pimentel

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    Yves Laure Pimentel · 57問 · 2年前

    MAJOR LIPOPROTEINS

    MAJOR LIPOPROTEINS

    57問 • 2年前
    Yves Laure Pimentel

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    Yves Laure Pimentel · 63問 · 2年前

    MINOR LIPOPROTEINS

    MINOR LIPOPROTEINS

    63問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 37問 · 2年前

    PROTEINS

    PROTEINS

    37問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    Yves Laure Pimentel · 91問 · 2年前

    PLASMA PROTEINS 1

    PLASMA PROTEINS 1

    91問 • 2年前
    Yves Laure Pimentel

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    Yves Laure Pimentel · 98問 · 2年前

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    PLASMA PROTEINS 2 (ALPHA 2 REGION)

    98問 • 2年前
    Yves Laure Pimentel

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    Yves Laure Pimentel · 61問 · 2年前

    MISCELLANEOUS PROTEINS

    MISCELLANEOUS PROTEINS

    61問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 1

    Liver Function Test 1

    Yves Laure Pimentel · 100問 · 2年前

    Liver Function Test 1

    Liver Function Test 1

    100問 • 2年前
    Yves Laure Pimentel

    Liver Function Test 2

    Liver Function Test 2

    Yves Laure Pimentel · 96問 · 2年前

    Liver Function Test 2

    Liver Function Test 2

    96問 • 2年前
    Yves Laure Pimentel

    TUMOR MARKERS

    TUMOR MARKERS

    Yves Laure Pimentel · 33問 · 2年前

    TUMOR MARKERS

    TUMOR MARKERS

    33問 • 2年前
    Yves Laure Pimentel

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    Yves Laure Pimentel · 41問 · 2年前

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

    41問 • 2年前
    Yves Laure Pimentel

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    Yves Laure Pimentel · 17問 · 2年前

    GLYCOGEN STORAGE DISEASES

    GLYCOGEN STORAGE DISEASES

    17問 • 2年前
    Yves Laure Pimentel

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    Yves Laure Pimentel · 14問 · 2年前

    LIPID STORAGE DISEASES

    LIPID STORAGE DISEASES

    14問 • 2年前
    Yves Laure Pimentel

    PROTEINS

    PROTEINS

    Yves Laure Pimentel · 71問 · 2年前

    PROTEINS

    PROTEINS

    71問 • 2年前
    Yves Laure Pimentel

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    Yves Laure Pimentel · 7問 · 2年前

    QUICK FIRE- ELECTRODES

    QUICK FIRE- ELECTRODES

    7問 • 2年前
    Yves Laure Pimentel

    ELECTROLYTES

    ELECTROLYTES

    Yves Laure Pimentel · 10問 · 2年前

    ELECTROLYTES

    ELECTROLYTES

    10問 • 2年前
    Yves Laure Pimentel

    DRUGS

    DRUGS

    Yves Laure Pimentel · 27問 · 2年前

    DRUGS

    DRUGS

    27問 • 2年前
    Yves Laure Pimentel

    TOXIC AGENTS:

    TOXIC AGENTS:

    Yves Laure Pimentel · 12問 · 2年前

    TOXIC AGENTS:

    TOXIC AGENTS:

    12問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    Yves Laure Pimentel · 100問 · 2年前

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    HEMATOLOGY 1 (HEMATOPOIESIS 1)

    100問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    Yves Laure Pimentel · 29問 · 2年前

    HEMATOLOGY (HEMATOPOIESIS 2)

    HEMATOLOGY (HEMATOPOIESIS 2)

    29問 • 2年前
    Yves Laure Pimentel

    hema diseases

    hema diseases

    Yves Laure Pimentel · 25問 · 2年前

    hema diseases

    hema diseases

    25問 • 2年前
    Yves Laure Pimentel

    AML

    AML

    Yves Laure Pimentel · 43問 · 2年前

    AML

    AML

    43問 • 2年前
    Yves Laure Pimentel

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    Yves Laure Pimentel · 71問 · 2年前

    GLOBIN SYNTHESIS

    GLOBIN SYNTHESIS

    71問 • 2年前
    Yves Laure Pimentel

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    Yves Laure Pimentel · 31問 · 2年前

    HEMATOLOGY REFERENCE RANGES

    HEMATOLOGY REFERENCE RANGES

    31問 • 2年前
    Yves Laure Pimentel

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    Yves Laure Pimentel · 34問 · 2年前

    DISORDERS OF PRIMARY HEMOSTASIS

    DISORDERS OF PRIMARY HEMOSTASIS

    34問 • 2年前
    Yves Laure Pimentel

    PLATELET DISORDERS

    PLATELET DISORDERS

    Yves Laure Pimentel · 37問 · 2年前

    PLATELET DISORDERS

    PLATELET DISORDERS

    37問 • 2年前
    Yves Laure Pimentel

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    Yves Laure Pimentel · 100問 · 2年前

    CHARACTERISTICS OF CLOTTING FACTORS

    CHARACTERISTICS OF CLOTTING FACTORS

    100問 • 2年前
    Yves Laure Pimentel

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    Yves Laure Pimentel · 12問 · 2年前

    4. CLASSIFICATION OF MACROPHAGE

    4. CLASSIFICATION OF MACROPHAGE

    12問 • 2年前
    Yves Laure Pimentel

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    Yves Laure Pimentel · 39問 · 2年前

    3. NATURAL OR INNATE IMMUNITY

    3. NATURAL OR INNATE IMMUNITY

    39問 • 2年前
    Yves Laure Pimentel

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    Yves Laure Pimentel · 55問 · 2年前

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

    55問 • 2年前
    Yves Laure Pimentel

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    Yves Laure Pimentel · 37問 · 2年前

    6. PHAGOCYTOSIS Chemotaxis

    6. PHAGOCYTOSIS Chemotaxis

    37問 • 2年前
    Yves Laure Pimentel

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    Yves Laure Pimentel · 44問 · 2年前

    8. NATURE OF ANTIGEN

    8. NATURE OF ANTIGEN

    44問 • 2年前
    Yves Laure Pimentel

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    Yves Laure Pimentel · 50問 · 2年前

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

    50問 • 2年前
    Yves Laure Pimentel

    1. HISTORY

    1. HISTORY

    Yves Laure Pimentel · 69問 · 2年前

    1. HISTORY

    1. HISTORY

    69問 • 2年前
    Yves Laure Pimentel

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    Yves Laure Pimentel · 38問 · 2年前

    2. TYPES OF IMMUNITY

    2. TYPES OF IMMUNITY

    38問 • 2年前
    Yves Laure Pimentel

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    Yves Laure Pimentel · 21問 · 2年前

    7. PHAGOCYTOSIS Engulfment and Digestion

    7. PHAGOCYTOSIS Engulfment and Digestion

    21問 • 2年前
    Yves Laure Pimentel

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    Yves Laure Pimentel · 15問 · 2年前

    8. PHAGOCYTOSIS EXOCYTOSIS

    8. PHAGOCYTOSIS EXOCYTOSIS

    15問 • 2年前
    Yves Laure Pimentel

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    Yves Laure Pimentel · 32問 · 2年前

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

    32問 • 2年前
    Yves Laure Pimentel

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    Yves Laure Pimentel · 30問 · 2年前

    11. TRANSPLANTATION IMMUNOLOGY

    11. TRANSPLANTATION IMMUNOLOGY

    30問 • 2年前
    Yves Laure Pimentel

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    Yves Laure Pimentel · 38問 · 2年前

    2. LYMPHOID ORGANS

    2. LYMPHOID ORGANS

    38問 • 2年前
    Yves Laure Pimentel

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    Yves Laure Pimentel · 48問 · 2年前

    3. CLUSTER OF DIFFERENTIATION

    3. CLUSTER OF DIFFERENTIATION

    48問 • 2年前
    Yves Laure Pimentel

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    Yves Laure Pimentel · 35問 · 2年前

    4. T-CELL DIFFERENTIATION

    4. T-CELL DIFFERENTIATION

    35問 • 2年前
    Yves Laure Pimentel

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 18問 · 2年前

    5. T CELL IMMUNODEFICIENCIES

    5. T CELL IMMUNODEFICIENCIES

    18問 • 2年前
    Yves Laure Pimentel

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    Yves Laure Pimentel · 44問 · 2年前

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

    44問 • 2年前
    Yves Laure Pimentel

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    Yves Laure Pimentel · 23問 · 2年前

    7. B CELL IMMUNODEFICIENCIES

    7. B CELL IMMUNODEFICIENCIES

    23問 • 2年前
    Yves Laure Pimentel

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    Yves Laure Pimentel · 34問 · 2年前

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    8. COMBINED T CELL AND B CELL DEFICIENCIES

    34問 • 2年前
    Yves Laure Pimentel

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    Yves Laure Pimentel · 12問 · 2年前

    9. COMPARISON OF T AND B CELLS

    9. COMPARISON OF T AND B CELLS

    12問 • 2年前
    Yves Laure Pimentel

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    Yves Laure Pimentel · 16問 · 2年前

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

    16問 • 2年前
    Yves Laure Pimentel

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    Yves Laure Pimentel · 15問 · 2年前

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

    15問 • 2年前
    Yves Laure Pimentel

    12. ANTIBODY

    12. ANTIBODY

    Yves Laure Pimentel · 79問 · 2年前

    12. ANTIBODY

    12. ANTIBODY

    79問 • 2年前
    Yves Laure Pimentel

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    Yves Laure Pimentel · 97問 · 2年前

    13. TYPES OF ANTIBODIES

    13. TYPES OF ANTIBODIES

    97問 • 2年前
    Yves Laure Pimentel

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    Yves Laure Pimentel · 11問 · 2年前

    14. MONOCLONAL ANTIBODIES

    14. MONOCLONAL ANTIBODIES

    11問 • 2年前
    Yves Laure Pimentel

    1. INTERLEUKINS

    1. INTERLEUKINS

    Yves Laure Pimentel · 23問 · 2年前

    1. INTERLEUKINS

    1. INTERLEUKINS

    23問 • 2年前
    Yves Laure Pimentel

    2. INTERFERONS

    2. INTERFERONS

    Yves Laure Pimentel · 28問 · 2年前

    2. INTERFERONS

    2. INTERFERONS

    28問 • 2年前
    Yves Laure Pimentel

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    Yves Laure Pimentel · 8問 · 2年前

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

    8問 • 2年前
    Yves Laure Pimentel

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 19問 · 2年前

    4. COMPLEMENT SYSTEM

    4. COMPLEMENT SYSTEM

    19問 • 2年前
    Yves Laure Pimentel

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    Yves Laure Pimentel · 76問 · 2年前

    15. COMPLEMENT SYSTEM

    15. COMPLEMENT SYSTEM

    76問 • 2年前
    Yves Laure Pimentel

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    Yves Laure Pimentel · 21問 · 2年前

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    16. SYSTEM CONTROLS/COMPLEMENT REGULATION

    21問 • 2年前
    Yves Laure Pimentel

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    Yves Laure Pimentel · 29問 · 2年前

    17. COMPLEMENT AND DISEASE STATES

    17. COMPLEMENT AND DISEASE STATES

    29問 • 2年前
    Yves Laure Pimentel

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    Yves Laure Pimentel · 19問 · 2年前

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

    19問 • 2年前
    Yves Laure Pimentel

    19. CYTOKINES

    19. CYTOKINES

    Yves Laure Pimentel · 22問 · 2年前

    19. CYTOKINES

    19. CYTOKINES

    22問 • 2年前
    Yves Laure Pimentel

    20. INTERLEUKINS

    20. INTERLEUKINS

    Yves Laure Pimentel · 24問 · 2年前

    20. INTERLEUKINS

    20. INTERLEUKINS

    24問 • 2年前
    Yves Laure Pimentel

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    Yves Laure Pimentel · 21問 · 2年前

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21. INTERFERONS, TNF, TGF, CHEMOKINE

    21問 • 2年前
    Yves Laure Pimentel

    1. SERO

    1. SERO

    Yves Laure Pimentel · 54問 · 2年前

    1. SERO

    1. SERO

    54問 • 2年前
    Yves Laure Pimentel

    2. PRECIPITATION

    2. PRECIPITATION

    Yves Laure Pimentel · 38問 · 2年前

    2. PRECIPITATION

    2. PRECIPITATION

    38問 • 2年前
    Yves Laure Pimentel

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    Yves Laure Pimentel · 17問 · 2年前

    3. PASSIVE IMMUNODIFFUSION

    3. PASSIVE IMMUNODIFFUSION

    17問 • 2年前
    Yves Laure Pimentel

    4. OUCHTERLONY

    4. OUCHTERLONY

    Yves Laure Pimentel · 15問 · 2年前

    4. OUCHTERLONY

    4. OUCHTERLONY

    15問 • 2年前
    Yves Laure Pimentel

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    Yves Laure Pimentel · 9問 · 2年前

    5. ELECTROPHORETIC TECHNIQUE

    5. ELECTROPHORETIC TECHNIQUE

    9問 • 2年前
    Yves Laure Pimentel

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    Yves Laure Pimentel · 11問 · 2年前

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

    11問 • 2年前
    Yves Laure Pimentel

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    Yves Laure Pimentel · 29問 · 2年前

    7. IMMUNOFIXATION ELECTROPHORESIS

    7. IMMUNOFIXATION ELECTROPHORESIS

    29問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    Which two organs are considered the primary lymphoid organs in which immunocompetent cells originate and mature? A. Thyroid and Peyer’s patches B. Thymus and bone marrow C. Spleen and mucosal-associated lymphoid tissue (MALT) D. Lymph nodes and thoracic duct

    B. Thymus and bone marrow

  • 2

    What type of B cells are formed after antigen stimulation? A. Plasma cells and memory B cells B. Mature B cells C. Antigen-dependent B cells D. Receptor-activated B cells

    A. Plasma cells and memory B cells

  • 3

    T cells travel from the bone marrow to the thymus for maturation. What is the correct order of the maturation sequence for T cells in the thymus? A. Bone marrow to the cortex; after thymic education, released back to peripheral circulation B. Maturation and selection occur in the cortex; migration to the medulla; release of mature T cells to secondary lymphoid organs C. Storage in either the cortex or medulla; release of T cells into the peripheral circulation D. Activation and selection occur in the medulla; mature T cells are stored in the cortex until activated by antigen

    B. Maturation and selection occur in the cortex; migration to the medulla; release of mature T cells to secondary lymphoid organs

  • 4

    Which cluster of differentiation (CD) marker appears during the first stage of T-cell development and remains present as an identifying marker for T cells? A. CD1 B. CD2 C. CD3 D. CD4 or CD8

    B. CD2

  • 5

    Which markers are found on mature, peripheral helper T cells? A. CD1, CD2, CD4 B. CD2, CD3, CD8 C. CD1, CD3, CD4 D. CD2, CD3, CD4

    D. CD2, CD3, CD4

  • 6

    Which T cell expresses the CD8 marker and acts specifically, to kill tumors or virally infected cells? A. Helper T B. T suppressor C. T cytotoxic D. T inducer/suppressor

    C. T cytotoxic

  • 7

    How are cytotoxic T cells (TC cells) and natural killer (NK) cells similar? A. Require antibody to be present B. Effective against virally infected cells C. Recognize antigen in association with HLA class II markers D. Do not bind to infected cells

    B. Effective against virally infected cells

  • 8

    What is the name of the process by which phagocytic cells are attracted to a substance such as a bacterial peptide? A. Diapedesis B. Degranulation C. Chemotaxis D. Phagotaxis

    C. Chemotaxis

  • 9

    Which complement component is found in both the classic and alternative pathways? A. C1 B. C4 C. Factor D D. C3

    D. C3

  • 10

    Which immunoglobulin(s) help(s) initiate the classic complement pathway? A. IgA and IgD B. IgM only C. IgG and IgM D. IgG only

    C. IgG and IgM

  • 11

    How is complement activity destroyed in vitro? A. Heating serum at 56°C for 30 min B. Keeping serum at room temperature of 22°C for 1 hour C. Heating serum at 37°C for 45 min D. Freezing serum at 0°C for 24 hours

    A. Heating serum at 56°C for 30 min

  • 12

    Which region of the immunoglobulin molecule can bind antigen? A. Fab B. Fc C. CL D. CH

    A. Fab

  • 13

    What is the purpose of C3a, C4a, and C5a, the split products of the complement cascade? A. To bind with specific membrane receptors of lymphocytes and cause release of cytotoxic substances B. To cause increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils C. To bind with membrane receptors of macrophages to facilitate phagocytosis and the removal of debris and foreign substances D. To regulate and degrade membrane cofactor protein after activation by C3 convertase

    B. To cause increased vascular permeability, contraction of smooth muscle, and release of histamine from basophils

  • 14

    Which region determines whether an immunoglobulin molecule can fix complement? A. VH B. CH C. VL D. CL

    B. CH

  • 15

    Which immunoglobulin class(es) has (have) a J chain? A. IgM B. IgE and IgD C. IgM and sIgA D. IgG3 and IgA

    C. IgM and sIgA

  • 16

    Which immunoglobulin appears first in the primary immune response? A. IgG B. IgM C. IgA D. IgE

    B. IgM

  • 17

    Which immunoglobulin appears in highest titer in the secondary response? A. IgG B. IgM C. IgA D. IgE

    A. IgG

  • 18

    Which immunoglobulin can cross the placenta? A. IgG B. IgM C. IgA D. IgE

    A. IgG

  • 19

    Which immunoglobulin cross links mast cells to release histamine? A. IgG B. IgM C. IgA D. IgE

    D. IgE

  • 20

    All of the following are functions of immunoglobulins except: A. Neutralizing toxic substances B. Facilitating phagocytosis through opsonization C. Interacting with TC cells to lyse viruses D. Combining with complement to destroy cellular Antigens

    C. Interacting with TC cells to lyse viruses

  • 21

    Which of the following cell surface molecules is classified as an MHC class II antigen? A. HLA-A B. HLA-B C. HLA-C D. HLA-DR

    D. HLA-DR

  • 22

    Which of the following are products of HLA class III genes? A. T-cell immune receptors B. HLA-D antigens on immune cells C. Complement proteins C2, C4, and Factor B D. Immunoglobulin VL regions

    C. Complement proteins C2, C4, and Factor B

  • 23

    What molecule on the surface of most T cells recognizes antigen? A. IgT, a four-chain molecule that includes the tau heavy chain B. MHC protein, a two-chain molecule encoded by the HLA region C. CD3, consisting of six different chains D. TcR, consisting of two chains, alpha and beta

    D. TcR, consisting of two chains, alpha and beta

  • 24

    The T-cell antigen receptor is similar to immunoglobulin molecules in that it: A. Remains bound to the cell surface and is never secreted B. Contains V and C regions on each of its chains C. Binds complement D. Can cross the placenta and provide protection to a fetus

    B. Contains V and C regions on each of its chains

  • 25

    Toll-like receptors are found on which cells? A. T cells B. Dendritic cells C. B cells D. Large granular lymphocytes

    B. Dendritic cells

  • 26

    Macrophages produce which of the following proteins during antigen processing? A. IL-1 and IL-6 B. γ-Interferon C. IL-4, IL-5, and IL-10 D. Complement components C1 and C3

    A. IL-1 and IL-6

  • 27

    T regulator cells, responsible for controlling autoimmune antibody production, express which of the following phenotypes? A. CD3, CD4, CD8 B. CD3, CD8, CD25 C. CD3, CD4, CD25 D. CD8, CD25, CD56

    C. CD3, CD4, CD25

  • 28

    A superantigen, such as toxic shock syndrome toxin-1 (TSST-1), bypasses the normal antigen processing stage by binding to and cross linking: A. A portion of an immunoglobulin molecule and complement component C1 B. Toll-like receptors and an MHC class 1 molecule C. A portion of an immunoglobulin and a portion of a T-cell receptor D. A portion of a T-cell receptor and an MHC class II molecule

    D. A portion of a T-cell receptor and an MHC class II molecule

  • 29

    The interaction between an individual antigen and antibody molecule depends upon several types of bonds such as ionic bonds, hydrogen bonds, hydrophobic bonds, and van der Waals forces. How is the strength of this attraction characterized? A. Avidity B. Affinity C. Reactivity D. Valency

    B. Affinity

  • 30

    A laboratory is evaluating an enzyme-linked immunosorbent assay (ELISA) for detecting an antibody to cyclic citrullinated peptide (CCP), which is a marker for rheumatoid arthritis. The laboratory includes serum from healthy volunteers and patients with other connective tissue diseases in the evaluation. These specimens determine which factor of the assay? A. Sensitivity B. Precision C. Bias D. Specificity

    D. Specificity

  • 31

    The detection of precipitation reactions depends on the presence of optimal proportions of antigen and antibody. A patient’s sample contains a large amount of antibody, but the reaction in a test system containing antigen is negative. What has happened? A. Performance error B. Low specificity C. A shift in the zone of equivalence D. Prozone phenomenon

    D. Prozone phenomenon

  • 32

    Which part of the radial immunodiffusion (RID) test system contains the antisera? A. Center well B. Outer wells C. Gel D. Antisera may be added to any well

    C. Gel

  • 33

    What is the interpretation when an Ouchterlony plate shows crossed lines between wells 1 and 2 (antigen is placed in the center well and antisera in wells 1 and 2)? A. No reaction between wells 1 and 2 B. Partial identity between wells 1 and 2 C. Nonidentity between wells 1 and 2 D. Identity between wells 1 and 2

    C. Nonidentity between wells 1 and 2

  • 34

    Why is a chemiluminescent immunoassay (CIA) or enzyme immunoassay (EIA) the method of choice for detection of certain analytes, such as hormones, normally found in low concentrations? A. Because of low cross reactivity B. Because of high specificity C. Because of high sensitivity D. Because test systems may be designed as both competitive and noncompetitive assays

    C. Because of high sensitivity

  • 35

    What comprises the indicator system in an indirect ELISA for detecting antibody? A. Enzyme-conjugated antibody + chromogenic substrate B. Enzyme conjugated antigen + chromogenic substrate C. Enzyme + antigen D. Substrate + antigen

    A. Enzyme-conjugated antibody + chromogenic substrate

  • 36

    What outcome results from improper washing of a tube or well after adding the enzyme–antibody conjugate in an ELISA system? A. Result will be falsely decreased B. Result will be falsely increased C. Result will be unaffected D. Result is impossible to determine

    B. Result will be falsely increased

  • 37

    What would happen if the color reaction phase is prolonged in one tube or well of an ELISA test? A. Result will be falsely decreased B. Result will be falsely increased C. Result will be unaffected D. Impossible to determine

    B. Result will be falsely increased

  • 38

    Which type of nephelometry is used to measure immune complex formation almost immediately after reagent has been added? A. Rate B. Endpoint C. Continuous D. One dimensiona

    A. Rate

  • 39

    The absorbance of a sample measured by ELISA is greater than the highest standard. What corrective action should be taken? A. Extrapolate an estimated value from the highest reading B. Repeat the test using a standard of higher concentration C. Repeat the assay using one half the volume of the sample D. Dilute the test sample

    D. Dilute the test sample

  • 40

    A patient was suspected of having a lymphoproliferative disorder. After several laboratory tests were completed, the patient was found to have an IgMκ paraprotein. In what sequence should the laboratory tests leading to this diagnosis have been performed? A. Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE) B. Immunoglobulin levels followed by SPE C. Total lymphocyte count followed by immunoglobulin levels D. Immunoglobulin levels followed by urine protein electrophoresis

    A. Serum protein electrophoresis (SPE) followed by immunofixation electrophoresis (IFE)

  • 41

    An IFE performed on a serum sample showed a narrow dark band in the lanes containing anti-γ and anti-λ. How should this result be interpreted? A. Abnormally decreased IgG concentration B. Abnormal test result demonstrating monoclonal IgGλ C. Normal test result D. Impossible to determine without densitometric quantitation

    B. Abnormal test result demonstrating monoclonal IgGλ

  • 42

    An immunofluorescence microscopy assay (IFA) was performed, and a significant antibody titer was reported. Positive and negative controls performed as expected. However, the clinical evaluation of the patient was not consistent with a positive finding. What is the most likely explanation of this situation? A. The clinical condition of the patient changed since the sample was tested B. The pattern of fluorescence was misinterpreted C. The control results were misinterpreted D. The wrong cell line was used for the tes

    B. The pattern of fluorescence was misinterpreted

  • 43

    What corrective action should be taken when an indeterminate pattern occurs in an indirect IFA? A. Repeat the test using a larger volume of sample B. Call the physician C. Have another medical laboratory scientist read the slide D. Dilute the sample and retest

    D. Dilute the sample and retest

  • 44

    Which statement best describes passive agglutination reactions used for serodiagnosis? A. Such agglutination reactions are more rapid because they are a single-step process B. Reactions require the addition of a second antibody C. Passive agglutination reactions require biphasic incubation D. Carrier particles for antigen such as latex particles are used

    D. Carrier particles for antigen such as latex particles are used

  • 45

    What has happened in a titer, if tube Nos. 5–7 show a stronger reaction than tube Nos.1–4? A. Prozone reaction B. Postzone reaction C. Equivalence reaction D. Poor technique

    A. Prozone reaction

  • 46

    What is the titer in tube No. 8 if tube No. 1 is undiluted and dilutions are doubled? A. 64 B. 128 C. 256 D. 512

    B. 128

  • 47

    The directions for a slide agglutination test instruct that after mixing the patient’s serum and latex particles, the slide must be rotated for 2 minutes. What would happen if the slide were rotated for 10 minutes? A. Possible false-positive result B. Possible false-negative result C. No effect D. Depends on the amount of antibody present in the sample

    A. Possible false-positive result

  • 48

    Which outcome indicates a negative result in a complement fixation test? A. Hemagglutination B. Absence of hemagglutination C. Hemolysis D. Absence of hemolysis

    C. Hemolysis

  • 49

    What effect does selecting the wrong gate have on the results when cells are counted by flow cytometry? A. No effect B. Failure to count the desired cell population C. Falsely elevated results D. Impossible to determine

    B. Failure to count the desired cell population

  • 50

    Which statement best describes immunophenotyping? A. Lineage determination by detecting antigens on the surface of the gated cells using fluorescent antibodies B. Identification of cell maturity using antibodies to detect antigens within the nucleus C. Identification and sorting of cells by front and sidescatter of light from a laser D. Analysis of cells collected by flow cytometry using traditional agglutination reactions

    A. Lineage determination by detecting antigens on the surface of the gated cells using fluorescent antibodies

  • 51

    A flow cytometry scattergram of a bone marrow sample shows a dense population of cells located inbetween normal lymphoid and normal myeloid cells. What is the most likely explanation? A. The sample was improperly collected B. An abnormal cell population is present C. The laser optics are out of alignment D. The cells are most likely not leukocytes

    B. An abnormal cell population is present

  • 52

    What substance is detected by the rapid plasma reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests for syphilis? A. Cardiolipin B. Anticardiolipin antibody C. Anti-T. pallidum antibody D. Treponema pallidum

    B. Anticardiolipin antibody

  • 53

    What type of antigen is used in the RPR card test? A. Live treponemal organisms B. Killed suspension of treponemal organisms C. Cardiolipin D. Tanned sheep cells

    C. Cardiolipin

  • 54

    Which of the following is the most sensitive test to detect congenital syphilis? A. VDRL B. RPR C. Microhemagglutinin test for T. pallidum (MHA-TP) D. Polymerase chain reaction (PCR)

    D. Polymerase chain reaction (PCR)

  • 55

    A biological false-positive reaction is least likely with which test for syphilis? A. VDRL B. Fluorescent T. pallidum antibody absorption test (FTA-ABS) C. RPR D. All are equally likely to detect a false-positive Result

    B. Fluorescent T. pallidum antibody absorption test (FTA-ABS)

  • 56

    A 12-year-old girl has symptoms of fatigue and a localized lymphadenopathy. Laboratory tests reveal a peripheral blood lymphocytosis, a positive RPR, and a positive spot test for IM. What test should be performed next? A. HIV test by ELISA B. VDRL C. Epstein–Barr virus (EBV) specific antigen test D. Treponema pallidum particle agglutination (TP-PA) test

    D. Treponema pallidum particle agglutination (TP-PA) test

  • 57

    Which test is most likely to be positive in the tertiary stage of syphilis? A. FTA-ABS B. RPR C. VDRL D. Reagin screen test (RST)

    A. FTA-ABS

  • 58

    What is the most likely interpretation of the following syphilis serological results? A. Neurosyphilis B. Secondary syphilis C. Syphilis that has been successfully treated D. Biological false positive

    D. Biological false positive

  • 59

    Interpret the following quantitative RPR test results. A. Excess antibody, prozone effect B. Excess antigen, postzone effect C. Equivalence of antigen and antibody D. Impossible to interpret; testing error

    A. Excess antibody, prozone effect

  • 60

    Tests to identify infection with HIV fall into which three general classification types of tests? A. Tissue culture, antigen, and antibody tests B. Tests for antigens, antibodies, and nucleic acid C. DNA probe, DNA amplification, and Western blot tests D. ELISA, Western blot, and Southern blot tests

    B. Tests for antigens, antibodies, and nucleic acid

  • 61

    A woman who has had five pregnancies subsequently tests positive for HIV by Western blot. What is the most likely reason for this result? A. Possible cross-reaction with herpes or EBV antibodies B. Interference from medication C. Cross-reaction with HLA antigens in the antigen preparation D. Possible technical error

    C. Cross-reaction with HLA antigens in the antigen preparation

  • 62

    Interpret the following results for HIV infection. A. Positive for antibodies to human immunodeficiency virus, HIV-1 B. Positive for antibodies to human immunodeficiency virus, HIV-2 C. Cross reaction; biological false-positive result D. Additional testing required

    D. Additional testing required

  • 63

    What is the most likely explanation when antibody tests for HIV are negative but a polymerase chain reaction test performed 1 week later is positive? A. Probably not HIV infection B. Patient is in the “window phase” before antibody production C. Tests were performed incorrectly D. Clinical signs may be misinterpreted

    B. Patient is in the “window phase” before antibody production

  • 64

    What criteria constitute the classification system for HIV infection? A. CD4-positive T-cell count and clinical symptoms B. Clinical symptoms, condition, duration, and number of positive bands on Western blot C. Presence or absence of lymphadenopathy D. Positive bands on Western blot and CD8-positive T-cell count

    A. CD4-positive T-cell count and clinical symptoms

  • 65

    What is the main difficulty associated with the development of an HIV vaccine? A. The virus has been difficult to culture; antigen extraction and concentration are extremely laborious B. Human trials cannot be performed C. Different strains of the virus are genetically diverse D. Anti-idiotype antibodies cannot be developed

    C. Different strains of the virus are genetically diverse

  • 66

    What is the advantage of 4th-generation rapid HIV tests over earlier rapid HIV tests? A. They use recombinant antigens B. They detect multiple strains of HIV C. They detect p24 antigen D. They are quantitative

    C. They detect p24 antigen

  • 67

    Which method is used to test for HIV infection in infants who are born to HIV-positive mothers? A. ELISA B. Western blot test C. Polymerase chain reaction D. Viral culture

    C. Polymerase chain reaction

  • 68

    What is the most likely cause when a Western blot or ELISA is positive for all controls and samples? A. Improper pipetting B. Improper washing C. Improper addition of sample D. Improper reading

    B. Improper washing

  • 69

    What constitutes a diagnosis of viral hepatitis? A. Abnormal test results for liver enzymes B. Clinical signs and symptoms C. Positive results for hepatitis markers D. All of these options

    D. All of these options

  • 70

    Which of the following statements regarding infection with hepatitis D virus is true? A. Occurs in patients with HIV infection B. Does not progress to chronic hepatitis C. Occurs in patients with hepatitis B D. Is not spread through blood or sexual contact

    C. Occurs in patients with hepatitis B

  • 71

    All of the following hepatitis viruses are spread through blood or blood products except: A. Hepatitis A B. Hepatitis B C. Hepatitis C D. Hepatitis D

    A. Hepatitis A

  • 72

    Which hepatitis B marker is the best indicator of early acute infection? A. HBsAg B. HBeAg C. Anti-HBc D. Anti-HBs

    A. HBsAg

  • 73

    Which is the first antibody detected in serum after infection with hepatitis B virus (HBV)? A. Anti-HBs B. Anti-HBc IgM C. Anti-HBe D. All are detectable at the same time

    B. Anti-HBc IgM

  • 74

    Which antibody persists in low-level carriers of hepatitis B virus? A. IgM anti-HBc B. IgG anti-HBc C. IgM anti-HBe D. IgG anti-HBs

    B. IgG anti-HBc

  • 75

    Which hepatitis antibody confers immunity against reinfection with hepatitis B virus? A. Anti-HBc IgM B. Anti-HBc IgG C. Anti-HBe D. Anti-HBs

    D. Anti-HBs

  • 76

    What is the most likely explanation when a patient has clinical signs of viral hepatitis but tests negative for hepatitis A IgM, hepatitis B surface antigen, and hepatitis C Ab? A. Tests were performed improperly B. The patient does not have hepatitis C. The patient may be in the “core window” D. Clinical evaluation was performed improperly

    C. The patient may be in the “core window”

  • 77

    Which hepatitis B markers should be performed on blood products? A. HBsAg and anti-HBc B. Anti-HBs and anti-HBc C. HBeAg and HBcAg D. Anti-HBs and HBeAg

    A. HBsAg and anti-HBc

  • 78

    Which test, other than serological markers, is most consistently elevated in viral hepatitis? A. Antinuclear antibodies B. Alanine aminotransferase (ALT) C. Absolute lymphocyte count D. Lactate dehydrogenase

    B. Alanine aminotransferase (ALT)

  • 79

    If only anti-HBs is positive, which of the following can be ruled out? A. Hepatitis B virus vaccination B. Distant past infection with hepatitis B virus C. Hepatitis B immune globulin (HBIG) injection D. Chronic hepatitis B virus infection

    D. Chronic hepatitis B virus infection

  • 80

    Interpret the following results for EBV infection: IgG and IgM antibodies to viral capsid antigen (VCA) are positive. A. Infection in the past B. Infection with a mutual enhancer virus such as HIV C. Current infection D. Impossible to interpret; need more information

    C. Current infection

  • 81

    Which statement concerning non-Forssman heterophile antibody is true? A. It is not absorbed by guinea pig antigen B. It is absorbed by guinea pig antigen C. It does not agglutinate horse RBCs D. It does not agglutinate sheep RBCs

    A. It is not absorbed by guinea pig antigen

  • 82

    Given a heterophile antibody titer of 224, which of the following results indicate IM?

    A

  • 83

    Given a heterophile antibody titer of 224, which of the following results indicate serum sickness?

    C

  • 84

    4. Given a heterophile antibody titer of 224, which of the following results indicate an error in testing?

    B

  • 85

    Blood products are tested for which virus before being transfused to newborns? A. EBV B. Human T-lymphotropic virus II (HTLV-II) C. Cytomegalovirus (CMV) D. Hepatitis D virus

    C. Cytomegalovirus (CMV)

  • 86

    What is the endpoint for the antistreptolysin O (ASO) latex agglutination assay? A. Highest serum dilution that shows no agglutination B. Highest serum dilution that shows agglutination C. Lowest serum dilution that shows agglutination D. Lowest serum dilution that shows no agglutination

    B. Highest serum dilution that shows agglutination

  • 87

    Interpret the following ASO results: A. Positive Todd unit 125 B. Positive Todd unit 166 C. No antistreptolysin O present D. Impossible to interpret

    A. Positive Todd unit 125

  • 88

    Which control shows the correct result for a valid ASO test? A. SLO control, no hemolysis B. Red cell control, no hemolysis C. Positive control, hemolysis in all tubes D. Hemolysis in both SLO and red cell control

    B. Red cell control, no hemolysis

  • 89

    A streptozyme test was performed, but the result was negative, even though the patient showed clinical signs of a streptococcal throat infection. What should be done next? A. Either ASO or anti-deoxyribonuclease B (antiDNase B) testing B. Another streptozyme test using diluted serum C. Antihyaluronidase testing D. Wait for 3–5 days and repeat the streptozyme test

    A. Either ASO or anti-deoxyribonuclease B (antiDNase B) testing

  • 90

    Rapid assays for influenza that utilize specimens obtained from nasopharyngeal swabs detect: A. IgM anti-influenza B. IgA anti-influenza C. IgA-influenza Ag immune complexes D. Influenza antigen

    D. Influenza antigen

  • 91

    How can interfering cold agglutinins be removed from a test sample? A. Centrifuge the serum and remove the top layer B. Incubate the clot at 1°C–4°C for several hours, then remove serum C. Incubate the serum at 56°C in a water bath for 30 minutes D. Use an anticoagulated sample

    B. Incubate the clot at 1°C–4°C for several hours, then remove serum

  • 92

    All tubes (dilutions) except the negative control are positive for cold agglutinins. This indicates: A. Contaminated red cells B. A rare antibody against red cell antigens C. The sample was stored at 4°C prior to separating serum and cells D. Further serial dilution is necessary

    D. Further serial dilution is necessary

  • 93

    All positive cold agglutinin tubes remain positive after 37°C incubation except the positive control. What is the most likely explanation for this situation? A. High titer cold agglutinins B. Contamination of the test system C. Antibody other than cold agglutinins D. Faulty water bath

    C. Antibody other than cold agglutinins

  • 94

    Which increase in antibody titer (dilution) best indicates an acute infection? A. From 1:2 to 1:8 B. From 1:4 to 1:16 C. From 1:16 to 1:256 D. From 1:64 to 1:128

    C. From 1:16 to 1:256

  • 95

    Which of the following positive antibody tests may be an indication of recent vaccination or early primary infection for rubella in a patient with no clinical symptoms? A. Only IgG antibodies positive B. Only IgM antibodies positive C. Both IgG and IgM antibodies positive D. Fourfold rise in titer for IgG antibodies

    B. Only IgM antibodies positive

  • 96

    Why is laboratory diagnosis difficult in cases of Lyme disease? A. Clinical response may not be apparent upon initial infection; IgM antibody may not be detected until 3–6 weeks after the infection B. Laboratory tests may be designed to detect whole Borrelia burgdorferi, not flagellar antigen found early in infection C. Most laboratory tests are technically demanding and lack specificity

    A. Clinical response may not be apparent upon initial infection; IgM antibody may not be detected until 3–6 weeks after the infection

  • 97

    Serological tests for which disease may give a false positive result if the patient has Lyme disease? A. AIDS B. Syphilis C. Cold agglutinins D. Hepatitis C

    B. Syphilis

  • 98

    In monitoring an HIV-infected patient, which parameter may be expected to be the most sensitive indicator of the effectiveness of antiretroviral treatment? A. HIV antibody titer B. CD4:CD8 ratio C. HIV viral load D. Absolute total T-cell count

    C. HIV viral load

  • 99

    A renal transplant recipient is found to have a rising creatinine level and reduced urine output. The physician orders a “Urine PCR” assay. When you call to find out what organism the physician wants to identify, you are told: A. Hepatitis C virus B. Legionella pneumophila C. EBV D. BK virus

    D. BK virus

  • 100

    A newborn is to be tested for a vertically transmitted HIV infection. Which of the following tests is most useful? A. HIV PCR B. CD4 count C. Rapid HIV antibody test D. HIV IgM antibody tes

    A. HIV PCR